We are live on
!
Find out more
HP
Holowesko Partners Portfolio holdings
AUM
$357M
1-Year Est. Return
15.03%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+15.03%
3 Year Est. Return
+52.08%
5 Year Est. Return
+74.71%
10 Year Est. Return
+175.23%
AUM
$373M
AUM Growth
+$1.37M
(+0.37%)
Cap. Flow
-$37.5M
Cap. Flow
% of AUM
-10.06%
Top 10 Holdings %
Top 10 Hldgs %
71.67%
Holding
35
New
5
Increased
5
Reduced
6
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$22.4M |
| 2 |
Kimberly-Clark
KMB
|
+$15.9M |
| 3 |
RTX Corp
RTX
|
+$14M |
| 4 |
Pfizer
PFE
|
+$12.2M |
| 5 |
Alibaba
BABA
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$31.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$28.8M |
| 3 |
Wells Fargo
WFC
|
+$5.88M |
| 4 |
Qualcomm
QCOM
|
+$4.98M |
| 5 |
Cigna
CI
|
+$3.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.6% |
| 2 | Financials | 16.83% |
| 3 | Industrials | 16.7% |
| 4 | Energy | 14.67% |
| 5 | Healthcare | 11.08% |
Similar funds
CCM
MWM
RM
SFP
PWAC
SWM
WKWM
WPC
Holowesko Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Holowesko Partners held 35 positions worth $373M, up 0.37% from $371M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Holowesko Partners withdrew a net $37.5M in Q1 2021, closing 8 positions and reducing 6 holdings. Its most notable exit was Gilead Sciences, an estimated $2.85M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
Against the trend, Holowesko Partners opened a new position in Kellanova worth $23.8M.
- Holowesko Partners's largest Q1 2021 buy was Kellanova: 400,440 shares worth $23.8M.
- Holowesko Partners added most to RTX Corp in Q1 2021, an estimated $14M increase.
- Holowesko Partners's biggest Q1 2021 reduction was Johnson & Johnson, cutting an estimated $31.6M.
- Holowesko Partners fully exited Gilead Sciences in Q1 2021, selling an estimated $2.85M.
- Holowesko Partners's ten largest holdings make up 72% of its $373M portfolio in Q1 2021.
- Holowesko Partners opened 5 new positions and closed 8 in Q1 2021.
- Holowesko Partners's portfolio value rose 0.37% quarter-over-quarter to $373M.
Based on Holowesko Partners's 13F filing for Q1 2021, filed 13 May 2021.